Rajan Gupta, MD
Pain Medicine · Cherry Hill, NJNPI 1114997962
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,257 of the $28,084 with a category attached, or 97.1%. Bracco Diagnostics Inc. accounts for 97.1% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $27,372, more than ten times the $341 reported in 2021. Among pain medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $1080.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bracco Diagnostics Inc.$27K
- Si-bone, Inc.$524
- Teva Pharmaceuticals USA, Inc.$132
- International Rehabilitative Sciences, Inc$36
- Acumed LLC$29
- AstraZeneca$29
- plus $77 from 4 others
What the payments were for
- Consulting fees$27,25797%
- Food & beverage$8273%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bracco Diagnostics Inc. | 3 | $27,257 |
| Si-bone, Inc. | 13 | $524 |
| Teva Pharmaceuticals USA, Inc. | 3 | $132 |
| International Rehabilitative Sciences, Inc | 1 | $36 |
| Acumed LLC | 1 | $29 |
| AstraZeneca | 1 | $29 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Pfizer | 1 | $19 |
| Medtronic | 1 | $18 |
| Curonix LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUMASON$27,257
- iFuse Implant$231
- AUSTEDO$108
How this compares
$28,084 in reported general payments places this provider in the 95th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 28 | $406 |
| Tramadol Hcl | 73 | $283 |
| Cyclobenzaprine Hcl | 15 | $190 |
| Celecoxib | 18 | $183 |
| Duloxetine Hcl | 20 | $168 |
| Ibuprofen | 12 | $71 |
| Tizanidine Hcl | 11 | $56 |
| Topiramate | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Cherry Hill
- Johan ReyesCherry Hill$6K
- Steven McGrathCherry Hill$5K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.